0001204938-17-000005.txt : 20170605
0001204938-17-000005.hdr.sgml : 20170605
20170605174522
ACCESSION NUMBER: 0001204938-17-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170601
FILED AS OF DATE: 20170605
DATE AS OF CHANGE: 20170605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolent Health, Inc.
CENTRAL INDEX KEY: 0001628908
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741]
IRS NUMBER: 320454912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
BUSINESS PHONE: 571-389-6000
MAIL ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WILLIAMS FRANK J
CENTRAL INDEX KEY: 0001204938
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37415
FILM NUMBER: 17892368
MAIL ADDRESS:
STREET 1: 2445 M STREET, NW
CITY: WASHINGTON
STATE: DC
ZIP: 20037
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-06-01
0
0001628908
Evolent Health, Inc.
EVH
0001204938
WILLIAMS FRANK J
C/O EVOLENT HEALTH, INC.
800 N. GLEBE ROAD, SUITE 500
ARLINGTON
VA
22203
1
1
0
0
Chief Executive Officer
Class A Common Stock
2017-06-01
4
S
0
4500
23.49
D
845983
D
Class A Common Stock
2017-06-01
4
S
0
11800
24.36
D
834183
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016.
The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.90-$23.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.00-$24.60, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Jonathan Weinberg, Attorney-in-fact
2017-06-05